Journal
DRUG DISCOVERY TODAY
Volume 9, Issue 6, Pages 276-285Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1359-6446(03)03008-3
Keywords
-
Categories
Ask authors/readers for more resources
Although computational tools have been used to predict tosic responses resulting from molecules binding either as substrates or inhibitors to proteins, there are complications to be resolved. Some proteins appear promiscuous in their ability to bind a diverse array of hydrophobic molecule. This promiscuity arises from the binding site simultaneously accomodating more than one molecule, multiple seperate binding sites, protein flexibility, or a combination of all these properties. With the availability, or more crystal structures for these non-target proteins, we should be able to predict binding in silico with a greater accuracy, thus avoiding or managing toxic side effects, therefore ultimately improving the success of drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available